跳至主要内容
临床试验/ITMCTR1900002562
ITMCTR1900002562招募中未知

Efficacy and safety of catheter ablation for atrial fibrillation guided by noninvasive three-dimensional electrocardiographic mapping: a randomized controlled trial

First Affiliated Hospital of Zhejiang Chinese Medical University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • 1. Patients diagnosed with paroxysmal and persistent atrial fibrillation;
  • 2. Patients aged between 18 and 80 years old;
  • 3. Patients undergoing atrial fibrillation radiofrequency catheter ablation;
  • 4. Informed consent can be obtained.

排除标准

  • 1. Long-standing persistent or permanent atrial fibrillation;
  • 2. Combined with other malignant arrhythmia such as sustained ventricular tachycardia;
  • 3. Blood clots in the heart;
  • 4. NYHA cardiac functional grading >=level III;
  • 5. Other severe cardiac dysfunction, cardiac ion channel diseases, inherited arrhythmogenic diseases and so on;
  • 6. Complicated with other severe diseases (e.g. hepatic and renal dysfunction, malignant tumor);
  • 7. Pregnancy or be allergic to iodine contrast medium.

研究者

发起方
First Affiliated Hospital of Zhejiang Chinese Medical University

相似试验

进行中(未招募)
Unknown
A Study of the Outcome of Catheter Ablation for Atrial Fibrillation Complicated by Hypertrophic CardiomyopathyHypertrophioc cardiomyopathyHypertrophic cardiomyopathy, atrial fibrillationD002312
JPRN-jRCT1020230057Kinjo Takahiko60
已完成
不适用
CAPLA trial: Catheter Ablation for persistent atrial fibrillation: A Multicentre randomised trial of Pulmonary vein antral isolation (PVAI) vs PVAI with posterior left atrial wall isolation (PWI).Cardiovascular - Other cardiovascular diseasesSurgery - Surgical techniquesatrial fibrillation
ACTRN12616001436460Alfred Hospital338
尚未招募
不适用
CAtheter-Based Ablation of atrial fibrillation compared to conventional treatment in patients with Heart Failure with Preserved Ejection Fraction - Investigator-initiated, prospective, parallel-group, randomized, open, blinded endpoint assessment (PROBE), interventional multicenter strategy trialAtrial fibrillation and HFpEFheart failure with a preserved ejection fraction10007521
NL-OMON56877Charité Universitätsmedizin Berlin150
进行中(未招募)
不适用
Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation TrialAtrial fibrillation
EUCTR2011-002532-12-CZMayo Clinic3,000
进行中(未招募)
1 期
Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation TrialMedDRA version: 19.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersAtrial fibrillation
EUCTR2011-002532-12-DEMayo Clinic2,200
Research on New Prevention and Treatment Technology... | 临床试验